Sam Fazeli is a renowned Pharmacologist and European Research Head, Pharmaceuticals Analyst at Bloomberg Intelligence. He has a vast educational background, having studied a Bachelor's degree in Pharmacology at Heath hospital school of medicine and completed a Doctor of Philosophy - PhD, Pharmacology at the University of London. With extensive experience in the pharmaceutical industry, Sam has been a Non-Executive Director at EXONATE LIMITED and Arecor Limited, and previously served as Head of research and pharmaceuticals analyst at Piper Jaffray.

Sam's research and analytical skills are unparalleled, and his expertise in the pharma industry is recognized worldwide. His experience in the corporate world, combined with his educational background, makes him a valuable asset to any organization he works with. In his current role at Bloomberg, he leads the European research team and provides critical insight into the pharmaceutical and biotech sectors.